Omeros Corporation (OMER) Social Stream



Omeros Corporation (OMER): $6.95

2.76 (+65.87%)

POWR Rating

Component Grades

Momentum

C

Stability

C

Sentiment

Quality

B

Add OMER to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#169 of 333

in industry

OMEROS CORP (OMER) Price Targets From Analysts

The tables below show price targets and recommendations from analysts covering OMEROS CORP.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-12-02 7 $34 $12 $21.75 $3.95 450.63%
2022-01-17 7 $25 $12 $18.25 $3.95 362.03%
2022-02-01 6 $20 $12 $16 $3.95 305.06%
2022-05-11 6 $20 $12 $15.666 $3.95 296.61%
2022-05-17 6 $20 $12 $14.666 $3.95 271.29%
2022-06-08 6 $20 $4 $12 $3.95 203.8%
2022-08-10 5 $20 $4.5 $12.166 $3.95 208%
2022-08-13 5 $20 $8 $13.333 $3.95 237.54%
2022-09-17 4 $20 $8 $13.333 $3.95 237.54%
2022-11-08 4 $20 $3 $11.666 $3.95 195.34%
2022-11-11 4 $13 $3 $8 $3.95 102.53%
2022-12-08 4 $13 $2 $6 $3.95 51.9%
2023-01-26 5 $13 $2 $6 $3.95 51.9%
2023-02-07 4 $13 $2 $5.833 $3.95 47.67%
2023-07-10 4 $13.001 $2 $6.333 $3.95 60.33%
2023-08-14 3 $13 $2 $6.333 $3.95 60.33%
2023-10-20 3 $2 $0.5 $1.25 $3.95 -68.35%

The Trend in the Analyst Price Target


Over the past 32 months, OMER's average price target has gone down $32.64.

OMER reports an average of 67.17% for its upside potential over the past 38 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2023-01-26 5 13 2.0 6.000 2.53 137.15%
2023-02-07 4 13 2.0 5.833 5.13 13.7%
2023-03-13 4 13 2.0 6.333 3.45 83.57%
2023-10-16 3 13 0.5 5.166 1.54 235.45%
2023-10-20 2 2 0.5 1.250 1.23 1.63%

OMER Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
3.33 0 0 2 0 0 3

The Trend in the Broker Recommendations


Over the past 14 months, OMER's average broker recommendation rating worsened by 0.9.

The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.

  • OMER has a greater average analyst price target than 258.22% of all US stocks.
  • To contextualize these metrics, consider that out of all US stocks, OMEROS CORP's variance in analysts' estimates is lower than -1733.65% of them.
  • OMEROS CORP's upside potential (average analyst target price relative to current price) is greater than 1635.59% of all US stocks.
  • OMEROS CORP's number of analysts covering the stock is greater than 512.1% of Healthcare stocks.

In the Pharmaceutical Products industry, MACK, ALIM, and MEIP are the three stocks most similar to OMEROS CORP regarding the price target and analyst recommendation information presented here.

Is OMER a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!